Differences
This shows you the differences between two versions of the page.
| — | conferences:usgeb11 [2020/06/10 21:42] (current) – created - external edit 127.0.0.1 | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| + | ====== Notes from USGEB11 ====== | ||
| + | [[http:// | ||
| + | ====== Thursday 27.01.2011 ====== | ||
| + | ===== Plenary Lecture I ===== | ||
| + | Seeing Cells in Action with photoactivatable fluorescent Proteins | ||
| + | * Photo-activated light microscopy -> Super-resolution | ||
| + | * Autophagy -> self-destruction of cell | ||
| + | * correlative imaging [[https:// | ||
| + | * 3D imaging possible | ||
| + | * wave from photon is propagated through two objectives | ||
| + | * interference makes it possible to extract 3D position | ||
| + | ===== Brain Imaging - Symposium D ===== | ||
| + | ==== Rolf Grütter - Imaging Brain Metabolism ==== | ||
| + | * Brain glucose level is linear to plasma glucose | ||
| + | * Brain glucose content mapped using < | ||
| + | * Spectroscopy can be used to emasuera concentration of biochemical compounds | ||
| + | * Concentration > 1 MM | ||
| + | * water soluble | ||
| + | * -> quantitative tool | ||
| + | ==== Corrado Corradi - felt and observed pain... ==== | ||
| + | * Analysis of activation patterns of brain regions of observed and experienced pain -> localized in one single part of the brain | ||
| + | ==== Beat Riederer - Imaging Brain Protein ==== | ||
| + | ==== Christophe Lamy - Imaging Sodium in Tissue ==== | ||
| + | ===== Exploring Biological Matter by Different Imaging Modalities - Symposium H ===== | ||
| + | ==== C. Cremer Nanoscopy of Nuclear Architecture ==== | ||
| + | * distribution of cells in Nucleus -> Super-resolution | ||
| + | * Merging of several images together | ||
| + | ==== David Müller ==== | ||
| + | * AFM imaging | ||
| + | ====== Friday 28.01.2011 ====== | ||
| + | ===== Imaging life using PET - Symposium J ===== | ||
| + | ==== Introduction ==== | ||
| + | * PET is quantitative, | ||
| + | < | ||
| + | ==== Windhorst - New PET Pharaceuticals in Oncology ==== | ||
| + | * Translational molecular imaging | ||
| + | * Molecular labeling with different compounds | ||
| + | * Makes personalized treatment possible, but needs testing for treatment with specific FDG-marker | ||
| + | ==== Tony Gee - PET in the CNS ==== | ||
| + | * Since markers have short half life, repeated studies are possible | ||
| + | * < | ||
| + | * Enzymes can be used, even Cocaine, Heroin and Nicotine. Can even be done without the pharmacological effect, since the markers can be labeled (which destroys the effect?) | ||
| + | * For antidepressants, | ||
| + | |||
| + | ==== Surekha Pimple - Evaluation of Quinazoline as PET Tracers ==== | ||
| + | * Development and characterization of new tracers for PET imaging | ||
| + | |||
| + | ==== Haibiao Gong - in vigo imaging of xenograft tumors ==== | ||
| + | * Near infrared imaging of tumors in vivo, follows by ex vivo imaging of the whole organ and tissue sectioning | ||
| + | * Activation of [[http:// | ||
| + | |||
| + | ==== Jana Doehner - Role of Reelin in brain tissue ==== | ||
| + | * Plays a role in Alzheimer research | ||
| + | * Expression of Reelin changes over aging | ||
| + | * Similarities between human and mouse plaques | ||
| + | |||
| + | ===== Plenary Lecture ===== | ||
| + | ==== Fritjof Helmchen - Emerging techniques for in vivo imaging of Neural Circuit Dynamics ==== | ||
| + | * Neocortex has several layers of neurons until the white matter | ||
| + | * Depth penetration into Neocortex around 800 um, into living tissue! | ||
| + | * Single action potentials through imaging combined wit electrical recording | ||
| + | * Two-photon imaging with ' | ||
| + | * Tradeoff between time resolution and size of Neuron population which can be imaged | ||
| + | * Plasticity effect in the brain (due to trimming of whiskers) | ||
| + | * Imaging in awake and behaving mice an be done with animals which are trained to tolerate head fixation | ||